Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  gastrointestinal complications
Trial Type:  Supportive care
Results 1-25 of 26 for your search:
Start Over
Radiation Therapy with or without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
Phase: Phase III
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 0920, NCI-2011-00878, CDR0000651536, NCT01311063, NCT00956007
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Phase: Phase III
Type: Supportive care
Age: 6 months to 21 years
Trial IDs: ACCL0934, NCI-2011-02636, CDR0000695661, COG-ACCL0934, NCT01371656
A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: AAA-III-01, NCI-2012-02037, 2011-005049-11, NCT01578239
Proton Beam or Intensity-Modulated Radiation Therapy in Treating Patients with Low or Low-Intermediate Risk Prostate Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 11-497, NCI-2012-01144, NCT01617161
Standard Radiation Therapy or Intensity-Modulated Pelvic Radiation Therapy in Treating Patients with Endometrial or Cervical Cancer
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: RTOG 1203, NCI-2012-02001, CDR0000738944, NCT01672892
Surgery or Non-surgical Management in Treating Patients with Intra-abdominal Cancer and Bowel Obstruction
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: S1316, NCI-2014-01497, SWOG-S1316, NCT02270450
Phase 3 Study With Cadazolid in CDAD (AC061A302)
Phase: Phase III
Type: Supportive care
Age: 18 and over
Trial IDs: AC-061A302, NCI-2014-02194, NCT01983683
The Efficacy of CASAD in Patients With Diarrhea Related to Medullary Thyroid Cancer
Phase: Phase II, Phase I
Type: Supportive care
Age: Not specified
Trial IDs: SAL 2012-0584, NCI-2014-00167, NCT01739634
Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer
Phase: Phase II, Phase I
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 201404101, NCI-2013-00650, NCT01790035
MatriStem Surgical Matrix PSM in Reducing Complications in Patients with Stomach or Esophageal Cancer Undergoing Surgery
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 13-178, NCI-2013-02006, NCT01970306
Pasireotide in Reducing Gastrointestinal Toxicity from Chemotherapy and Radiation in Patients Undergoing a Donor Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: Pro00051736, NCI-2014-02316, NCT02215070
A Study Looking the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide
Phase: Phase II
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: PUMA-NER-6201, NCI-2015-00769, NCT02400476
Autologous Fecal Microbiota Transplant in Preventing Clostridium Difficile Infection in Patients with Cancer Undergoing Donor Hematopoietic Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Age: 18 and over
Trial IDs: 14-025, NCI-2014-02206, NCT02269150
Rocking Chair Method in Reducing Surgical Stress Response in Patients Recovering from Abdominal Surgery
Phase: Phase I
Type: Supportive care
Age: 18 and over
Trial IDs: 2010-0129, NCI-2012-01884, NCT01200316
Belinostat in Treating Patients with Liver Cancer or Liver Dysfunction
Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 11-C-0060, NCI-2013-01474, 110060, P10739, 8846, NCT01273155
Neutropenic Diet in Preventing Infections in Younger Patients Receiving Chemotherapy
Phase: No phase specified
Type: Supportive care
Age: 1 to 21
Trial IDs: 06-08-367, NCI-2014-01519, NCI-2014-01460, NCT00726934
Implanted Fiducial Markers in Assessing Treatment Accuracy and Esophageal Toxicity in Patients with Solid Tumors Undergoing Spinal Stereotactic Radiosurgery
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 2012-0190, NCI-2012-01244, NCT01624220
Home, Hospital, or Outpatient Clinic Follow-Up Care in Maintaining Normal Intestinal Bacteria Levels in Patients Who Have Undergone Stem Cell Transplant
Phase: No phase specified
Type: Health services research, Supportive care
Age: 18 to 80
Trial IDs: Pro00032263, NCI-2014-00024, NCT01725022
Dexamethasone in Reducing Oral Pain and Dry Mouth after Surgery in Patients with Oropharyngeal Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 andover
Trial IDs: 8071, NCI-2012-02780, CPC-12095-L, CR00021919, NCT01748942
Modified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer
Phase: No phase specified
Type: Diagnostic, Supportive care
Age: 40 to 89
Trial IDs: CCCWFU 97312, NCI-2012-02165, NCT01767961
Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Age: 19 and over
Trial IDs: RAD 1203, NCI-2013-01073, F121218006, UAB1240, NCT01856855
Individualized High Dose Methotrexate in Treating Younger Patients With Cancer and Significant Risk for Side Effects
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 1 to 22
Trial IDs: H-33119, NCI-2014-00923, NCT02076997
Chinese Herbal Formulation PHY906 in Reducing Side Effects Caused by Capecitabine and Radiation Therapy in Patients with Locally Advanced Rectal Cancer
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 1404013708, NCI-2014-01560, NCT02178644
Start Over